228 related articles for article (PubMed ID: 16983096)
21. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen.
Fujimuro M; Liu J; Zhu J; Yokosawa H; Hayward SD
J Virol; 2005 Aug; 79(16):10429-41. PubMed ID: 16051835
[TBL] [Abstract][Full Text] [Related]
22. Determination of Kaposi's sarcoma-associated herpesvirus C-terminal latency-associated nuclear antigen residues mediating chromosome association and DNA binding.
Kelley-Clarke B; Ballestas ME; Srinivasan V; Barbera AJ; Komatsu T; Harris TA; Kazanjian M; Kaye KM
J Virol; 2007 Apr; 81(8):4348-56. PubMed ID: 17287261
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen reduces interleukin-8 expression in endothelial cells and impairs neutrophil chemotaxis by degrading nuclear p65.
Li X; Liang D; Lin X; Robertson ES; Lan K
J Virol; 2011 Sep; 85(17):8606-15. PubMed ID: 21697472
[TBL] [Abstract][Full Text] [Related]
24. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.
Staudt MR; Dittmer DP
Virology; 2006 Jun; 350(1):192-205. PubMed ID: 16616289
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.
You J; Srinivasan V; Denis GV; Harrington WJ; Ballestas ME; Kaye KM; Howley PM
J Virol; 2006 Sep; 80(18):8909-19. PubMed ID: 16940503
[TBL] [Abstract][Full Text] [Related]
26. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA.
Barbera AJ; Chodaparambil JV; Kelley-Clarke B; Joukov V; Walter JC; Luger K; Kaye KM
Science; 2006 Feb; 311(5762):856-61. PubMed ID: 16469929
[TBL] [Abstract][Full Text] [Related]
27. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
Kedes DH; Lagunoff M; Renne R; Ganem D
J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
[TBL] [Abstract][Full Text] [Related]
28. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells.
Cotter MA; Robertson ES
Virology; 1999 Nov; 264(2):254-64. PubMed ID: 10562490
[TBL] [Abstract][Full Text] [Related]
29. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.
Kelley-Clarke B; Ballestas ME; Komatsu T; Kaye KM
Virology; 2007 Jan; 357(2):149-57. PubMed ID: 16979209
[TBL] [Abstract][Full Text] [Related]
31. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1.
Lim C; Lee D; Seo T; Choi C; Choe J
J Biol Chem; 2003 Feb; 278(9):7397-405. PubMed ID: 12486118
[TBL] [Abstract][Full Text] [Related]
32. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.
Chen W; Hilton IB; Staudt MR; Burd CE; Dittmer DP
J Virol; 2010 Apr; 84(8):3898-908. PubMed ID: 20130056
[TBL] [Abstract][Full Text] [Related]
33. Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8.
Kirsch P; Jakob V; Oberhausen K; Stein SC; Cucarro I; Schulz TF; Empting M
J Med Chem; 2019 Apr; 62(8):3924-3939. PubMed ID: 30888817
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus-encoded LANA positively affects on ubiquitylation of p53.
Suzuki T; Isobe T; Kitagawa M; Ueda K
Biochem Biophys Res Commun; 2010 Dec; 403(2):194-7. PubMed ID: 21056547
[TBL] [Abstract][Full Text] [Related]
35. Methylation of LOXL1 Promoter by DNMT3A in Aged Human Skin Fibroblasts.
Moulin L; Cenizo V; Antu AN; André V; Pain S; Sommer P; Debret R
Rejuvenation Res; 2017 Apr; 20(2):103-110. PubMed ID: 27396912
[TBL] [Abstract][Full Text] [Related]
36. Differential maintenance and de novo methylating activity by three DNA methyltransferases in aging and immortalized fibroblasts.
Lopatina N; Haskell JF; Andrews LG; Poole JC; Saldanha S; Tollefsbol T
J Cell Biochem; 2002; 84(2):324-34. PubMed ID: 11787061
[TBL] [Abstract][Full Text] [Related]
37. De novo DNA methyltransferase DNMT3A: Regulation of oligomeric state and mechanism of action in response to pH changes.
Holz-Schietinger C; Reich NO
Biochim Biophys Acta; 2015 Jun; 1850(6):1131-9. PubMed ID: 25681155
[TBL] [Abstract][Full Text] [Related]
38. Correction for Gjyshi et al., "Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression".
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2017 Dec; 91(23):. PubMed ID: 29138338
[No Abstract] [Full Text] [Related]
39. Linking DNA Damage and Age-Related Promoter DNA Hyper-Methylation in the Intestine.
Thalheim T; Herberg M; Galle J
Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29303998
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of DNA Methyltransferase Recruitment in Mammals.
Laisné M; Gupta N; Kirsh O; Pradhan S; Defossez PA
Genes (Basel); 2018 Dec; 9(12):. PubMed ID: 30544749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
